NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Diagnostics & Research · USD

Agilent Technologies, Inc. (A) Stock Analysis

Agilent Technologies, Inc. (A) is a Diagnostics & Research stock listed on NYSE and quoted in US Dollar.

A

$150.86

+$0.88 (+0.59%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare A with… →

A Key Statistics

As of Sep 4, 2026
Trading
Open
$148.97
Previous Close
$149.98
Day's Range
147.78–151.59
52-Week Range
108.35–163.75
Volume
1.83M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.24
Valuation
Market Cap
$42.54B
P/E Ratio
29.76
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
22.30
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.24
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
5.77
EPS (ttm)Profit attributable to each share over the last twelve months.
5.07
Financials (FY)
Revenue (FY)
$6.95B+6.73%
Net Income (FY)
$1.30B+1.09%
Profit marginThe share of revenue left as profit after all costs and taxes.
19.53%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
281.97M
1-Year Return
+18.36%
Dividend and dates
Dividend
$1.02+0.68%
Ex-Dividend Date
June 30, 2026
Earnings Date
November 25, 2026estimated
Avg Volume
2.22M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

A Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+11.54%
2025+1.92%
2024−2.70%
2023−6.42%
2022−5.52%
2021+35.51%
2020+39.79%
2019+27.54%
2018+1.67%
2017+48.32%
2016 (partial year)−3.02%

As of September 4, 2026.

A Revenue and Earnings by Fiscal Year

FY ends October
Fiscal yearRevenueNet incomeNet margin
2025$6.95B$1.30B18.8%
2024$6.51B$1.29B19.8%
2023$6.83B$1.24B18.1%
2022$6.85B$1.25B18.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$6.95B$3.64B$1.48B$1.30B18.8%
2024$6.51B$3.54B$1.49B$1.29B19.8%
2023$6.83B$3.47B$1.35B$1.24B18.1%
2022$6.85B$3.72B$1.62B$1.25B18.3%

Annual figures as reported, in the company's reporting currency. As of October 31, 2025.

A Dividend History

$0.74−22.2% vs 2024

Dividends per share, 2025 · 3 payments

YearDividends per sharePaymentsChange
2026*$0.773—
2025$0.743−22.2%
2024$0.964+4.9%
2023$0.914−14.5%
YearDividends per sharePaymentsChange
2026 (partial year)$0.773—
2025$0.743−22.2%
2024$0.964+4.9%
2023$0.914−14.5%
2022$1.075+37.2%
2021$0.784+43.7%
2020$0.543−19.6%
2019$0.674+10.0%
2018$0.614+12.1%
2017$0.554+120.6%
2016$0.252—

Most recent payment: $0.26 per share, ex-dividend June 30, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

A Valuation vs Diagnostics & Research Median

Median of 49 stocks
MetricADiagnostics & Research medianvs median
P/E29.7633.0810% below
P/S ratio5.774.9916% above
Profit margin19.53%0.00%19.5 pts above

Medians across 49 Diagnostics & Research stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Agilent Technologies, Inc. (A) carries a market capitalisation of $42.54B. The company sits in the Healthcare sector, in the Diagnostics & Research industry. The company reports 18,200 employees.

The most recent close on file for A is $150.86, dated September 4, 2026. That is +$0.88 (+0.59%) against the previous close. The 52-week range on file runs from $108.35 to $163.75. The latest close sits 39.23% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $6.95B. Against the prior fiscal year total of $6.51B, that is a change of +6.73%. The same year closed with net income of $1.30B. That is +1.09% against the prior fiscal year. Profit margin runs at 19.53%. That is 19.5 percentage points above the Diagnostics & Research median of 0%. Trailing earnings per share are 5.07.

Across the 4 fiscal years on file, revenue moves from $6.85B in 2022 to $6.95B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

A trades at a trailing price-to-earnings ratio of 29.76. That is 10.04% below the Diagnostics & Research median of 33.08. The forward P/E on file is 22.3. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.24. Measured against sales, the shares trade at 5.77 times revenue. On price-to-sales that is 15.63% above the Diagnostics & Research median of 4.99. The medians here are taken across 49 Diagnostics & Research companies that report the metric.

The trailing one-year price return is +18.36%. Measured over 10 years, that is +13.25% a year compounded. The reported beta is 1.24. Annualized volatility over the trailing 10 years is 28.29%.

Growth & Income

A pays a dividend yielding 0.68%. That is 0.1 percentage points below the Diagnostics & Research median yield of 0.76%. At the indicated rate that is $1.02 a share a year. The ex-dividend date on file is June 30, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $0.77 a share. The year before, 2025, totalled $0.74 a share.

Across the complete calendar years on file, 2017 returned +48.32% and 2023 returned −6.42%. Of the 9 complete calendar years on file, 6 finished higher. 2026 is still running; the price is +11.54% year to date.

Peer Comparison

Agilent Technologies, Inc. (A) operates in the Diagnostics & Research industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Agilent Technologies, Inc. A $42.54B 29.8
Thermo Fisher Scientific Inc. TMO $226.94B 33.0
Danaher Corporation DHR $145.98B 37.0
Natera, Inc. NTRA $47.31B —

The Diagnostics & Research industry average P/E ratio is 33.1x. Agilent Technologies, Inc. trades at a P/E of 29.8.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Diagnostics & Research Stocks

TMO

Thermo Fisher Scientific Inc.

$226.94B

 DHR

Danaher Corporation

$145.98B

 NTRA

Natera, Inc.

$47.31B

 IQV

IQVIA Holdings Inc.

$44.07B

 IDXX

IDEXX Laboratories, Inc.

$42.18B

 WAT

Waters Corporation

$40.20B
View all Diagnostics & Research stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Agilent Technologies, Inc.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Visit website →